FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• REXULTI (brexpiprazole)

Snippet

SUPPL AP for REXULTI (BREXPIPRAZOLE)